The Q4 FY26 results reveal a company in severe distress, with operating profit (PBDIT) excluding other income plunging to negative ₹1.35 crores from positive ₹0.54 crores in the year-ago quarter. The sequential performance deteriorated sharply as well, with net sales dropping from ₹8.00 crores in Q3 FY26 to zero in the March quarter. This complete cessation of revenue generation raises serious questions about the company's operational viability and future prospects.
Quarterly Trend: A Pattern of Deterioration
| Quarter | Net Sales (₹ Cr) | QoQ Growth | Net Profit (₹ Cr) | PAT Margin |
|---|---|---|---|---|
| Mar'26 | 0.00 | N/A | -1.30 | 0.0% |
| Dec'25 | 0.00 | -100.00% | -0.30 | 0.0% |
| Sep'25 | 8.00 | +38.17% | -0.29 | -3.63% |
| Jun'25 | 5.79 | -91.63% | 0.69 | 11.92% |
| Mar'25 | 69.16 | +403.71% | 3.24 | 4.68% |
| Dec'24 | 13.73 | -83.46% | 2.79 | 20.32% |
| Sep'24 | 83.03 | N/A | 0.70 | 0.84% |
The quarterly trend table reveals extreme volatility in Auri Grow India's operations. After posting robust sales of ₹69.16 crores in Q4 FY25, the company's revenue generation has effectively ceased over the past two quarters. The operating profit margin, which peaked at 30.08% in December 2024, has now collapsed entirely, with the company unable to generate any meaningful revenue to cover its fixed costs.
Financial Performance: A Complete Breakdown
The financial performance for Q4 FY26 represents an unprecedented collapse across all key metrics. With zero net sales, the company recorded an operating loss (PBDIT excluding other income) of ₹1.35 crores, the worst quarterly performance in its recent history. Employee costs remained minimal at zero, suggesting potential workforce reductions or complete operational suspension. Interest expenses were also zero, down from ₹0.26 crores in Q4 FY25, indicating either debt repayment or the absence of active borrowing facilities.
The profit before tax stood at negative ₹1.37 crores, with a minimal tax credit of ₹0.07 crores, resulting in the net loss of ₹1.30 crores. The company's inability to generate other income (zero in Q4 FY26 versus ₹3.92 crores in Q4 FY25) further exacerbated the losses. The earnings per share (EPS) for the quarter fell to negative ₹0.01, down from positive ₹0.05 in the year-ago period.
Critical Operational Concerns
Zero Revenue Generation: The complete absence of sales for two consecutive quarters signals a fundamental breakdown in the company's business operations. Whether due to loss of key clients, production halts, or strategic restructuring, the situation demands immediate management attention and transparent communication with stakeholders.
Deteriorating Financial Trend: The company's financial trend classification has shifted to "NEGATIVE" as of March 2026, with seven key negative factors identified, including the lowest-ever ROCE, PAT, and debtors turnover ratio. This represents a stark reversal from the "Outstanding" classification in December 2024.
Balance Sheet Strain and Liquidity Concerns
The balance sheet as of March 2025 (latest available annual data) reveals a company with significant structural challenges. Shareholder funds stood at ₹99.48 crores, comprising share capital of ₹91.37 crores and reserves of just ₹8.11 crores. The company's long-term debt increased substantially to ₹69.38 crores from ₹1.44 crores in the previous year, representing a 4,717% surge that financed the build-up in current assets.
Current assets ballooned to ₹272.29 crores from ₹65.13 crores, whilst current liabilities surged to ₹103.96 crores from ₹0.53 crores. Trade payables alone escalated to ₹94.66 crores, suggesting potential working capital stress and delayed payments to suppliers. Fixed assets declined to ₹0.43 crores from ₹2.29 crores, indicating asset sales or impairments. The company reported zero cash balances at year-end for both FY25 and FY24, highlighting severe liquidity constraints.
Profitability Metrics: Structural Weakness Exposed
The company's average return on equity (ROE) of 1.83% and average return on capital employed (ROCE) of negative 1.75% underscore fundamental profitability challenges. The latest ROCE of 3.12% and ROE of 4.12%, whilst positive, remain far below industry standards and reflect the company's struggle to generate adequate returns on invested capital. The five-year sales growth of negative 15.70% and EBIT growth of negative 6.36% paint a picture of long-term structural decline rather than temporary cyclical weakness.
| Profitability Metric | Value | Assessment |
|---|---|---|
| Average ROCE | -1.75% | Weak capital efficiency |
| Average ROE | 1.83% | Poor shareholder returns |
| Latest ROCE (FY25) | 3.12% | Below industry standards |
| Latest ROE (FY25) | 4.12% | Inadequate profitability |
| 5-Year Sales Growth | -15.70% | Persistent revenue decline |
The debt to EBITDA ratio of 4.81 times indicates high leverage relative to operating cash generation capacity, whilst the EBIT to interest coverage of just 1.58 times suggests limited ability to service debt obligations from operating profits. The company's sales to capital employed ratio of 0.43 times reflects poor asset utilisation, with every rupee of capital employed generating less than 50 paise in sales.
Peer Comparison: Lagging the Industrial Manufacturing Sector
| Company | P/E (TTM) | P/BV | ROE (%) | Debt/Equity |
|---|---|---|---|---|
| Auri Grow India | 7.35 | 0.30 | 1.83% | 0.08 |
| Gurunanak Agri. | 7.65 | 1.13 | 0.0% | 0.00 |
| Bombay Metrics | 30.39 | 2.23 | 15.00% | 0.45 |
| Manugraph India | NA (Loss Making) | 0.80 | 1.37% | 0.01 |
| Falcon | 31.25 | 1.58 | 5.15% | 1.34 |
Auri Grow India trades at a significant discount to most peers on a price-to-book basis (0.30x versus peer average of approximately 1.40x), reflecting market scepticism about the company's asset quality and future earnings potential. The P/E ratio of 7.35x appears superficially attractive but is based on trailing twelve-month earnings that include the profitable FY25 performance, which now appears unsustainable given the operational collapse in recent quarters.
The company's ROE of 1.83% lags considerably behind better-performing peers like Bombay Metrics (15.00%) and Falcon (5.15%), highlighting its inferior capital efficiency. Whilst Auri Grow India maintains lower leverage (debt-to-equity of 0.08) compared to some peers, this conservative capital structure has not translated into superior operational performance or shareholder returns.
Valuation Analysis: Deep Discount Reflects Fundamental Concerns
At the current market price of ₹0.32, Auri Grow India trades at a price-to-book value of just 0.30x, implying the market values the company's net assets at a 70% discount to book value. This substantial markdown reflects investor concerns about asset realisability, operational sustainability, and the company's ability to generate future cash flows. The stock has declined 68.00% from its 52-week high of ₹1.00, with the downward trajectory accelerating in recent months.
The company's valuation grade of "VERY ATTRACTIVE" appears misleading when considered alongside its "BELOW AVERAGE" quality grade and "NEGATIVE" financial trend. The enterprise value to sales ratio of 4.32x seems elevated given the complete absence of current revenue generation, whilst the negative EV/EBITDA and EV/EBIT ratios reflect the company's loss-making status. The book value per share of ₹1.09 provides a theoretical floor, but this assumes full asset realisability, which appears questionable given the operational shutdown.
Valuation Dashboard
P/E Ratio (TTM): 7.35x (Based on historical profitability)
Price to Book: 0.30x (70% discount to book value)
Dividend Yield: NA (No dividend history)
Mojo Score: 23/100 (STRONG SELL category)
Shareholding Pattern: Complete Absence of Institutional Support
| Shareholder Category | Mar'26 | Dec'25 | Sep'25 | Jun'25 |
|---|---|---|---|---|
| Promoter Holding | 0.00% | 0.00% | 0.00% | 0.00% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.07% |
| Mutual Fund Holding | 0.00% | 0.00% | 0.00% | 0.00% |
| Insurance Holdings | 0.00% | 0.00% | 0.00% | 0.00% |
| Non-Institutional | 100.00% | 100.00% | 100.00% | 99.93% |
The shareholding pattern reveals a company devoid of institutional backing, with 100% of shares held by non-institutional investors as of March 2026. The complete absence of promoter holding (0.00%) is highly unusual and raises governance concerns about ownership structure and management accountability. Foreign institutional investors (FIIs) held a nominal 0.07% stake in June 2025 but exited entirely by September 2025, signalling institutional disinterest.
The lack of mutual fund, insurance company, or other domestic institutional investor (DII) participation underscores the company's marginal status in the investment community. With no promoter skin in the game and zero institutional validation, the stock remains purely in the hands of retail and non-institutional investors, amplifying volatility and limiting access to patient capital.
Stock Performance: Severe Underperformance Across All Timeframes
| Period | Stock Return | Sensex Return | Alpha |
|---|---|---|---|
| 1 Week | +3.23% | +0.73% | +2.50% |
| 1 Month | -8.57% | -1.97% | -6.60% |
| 3 Months | +23.08% | -6.54% | +29.62% |
| 6 Months | -37.25% | -11.36% | -25.89% |
| YTD | -57.89% | -10.86% | -47.03% |
| 1 Year | -36.00% | -6.94% | -29.06% |
| 2 Years | -68.00% | +1.97% | -69.97% |
| 3 Years | -78.67% | +20.88% | -99.55% |
The stock performance data reveals systematic and severe underperformance across virtually all timeframes. Auri Grow India has delivered a catastrophic negative 36.00% return over the past year, underperforming the Sensex by 29.06 percentage points. The year-to-date decline of 57.89% represents one of the worst performances in the industrial manufacturing sector, with the stock generating negative alpha of 47.03 percentage points versus the benchmark.
Over longer periods, the destruction of shareholder wealth becomes even more apparent. The two-year return of negative 68.00% and three-year return of negative 78.67% contrast starkly with the Sensex's positive returns of 1.97% and 20.88% respectively during the same periods. The stock's beta of 1.50 indicates high volatility, with movements amplified 50% relative to the broader market. The risk-adjusted return of negative 0.72 and volatility of 49.89% classify the stock as "HIGH RISK LOW RETURN," the worst possible combination for investors.
Technical Analysis: Persistent Bearish Trend
The technical picture remains decidedly negative, with the stock in a "MILDLY BEARISH" trend since April 15, 2026. The stock trades below all key moving averages, including the 5-day MA (₹0.31), 20-day MA (₹0.32), 50-day MA (₹0.31), 100-day MA (₹0.38), and 200-day MA (₹0.49), signalling persistent selling pressure and lack of buying interest. The MACD indicator shows mildly bullish signals on both weekly and monthly timeframes, but this has not translated into sustained price recovery.
The Relative Strength Index (RSI) shows no clear signal, indicating the stock is neither oversold nor overbought at current levels. Bollinger Bands suggest mildly bearish to bearish conditions, with the stock trading near the lower band. The immediate support level rests at ₹0.20 (the 52-week low), whilst resistance emerges at ₹0.32 (20-day MA area), ₹0.38 (100-day MA), and ₹0.49 (200-day MA). The stock would need to reclaim these moving averages decisively to signal any meaningful technical reversal.
Investment Thesis: Multiple Red Flags Outweigh Valuation Discount
The Mojo Score of 23 out of 100 places Auri Grow India firmly in the "STRONG SELL" category, reflecting the convergence of negative factors across valuation, quality, financial trends, and technical indicators. Whilst the valuation grade appears "VERY ATTRACTIVE" with the stock trading at 0.30x book value, this discount reflects fundamental concerns rather than an investment opportunity.
Key Strengths
- Deep Valuation Discount: Trading at 0.30x book value, representing a 70% discount to net asset value
- Low Leverage: Debt-to-equity ratio of just 0.08, providing some financial flexibility
- No Promoter Pledging: Zero pledged shares eliminates one governance risk factor
- Micro-Cap Status: Potential for sharp recovery if operations normalise, given low base
- Asset Base: Book value of ₹1.09 per share provides theoretical downside cushion
Key Concerns
- Complete Revenue Collapse: Zero sales for two consecutive quarters signals operational breakdown
- Persistent Losses: Net loss of ₹1.30 crores in Q4 FY26, with negative operating margins
- Zero Promoter Holding: Complete absence of promoter stake raises serious governance questions
- No Institutional Support: Zero FII, MF, or insurance holdings indicates lack of credibility
- Negative Financial Trend: Seven key negative factors identified in latest financial assessment
- Severe Stock Underperformance: Down 68% over two years with negative 99.55% alpha over three years
- Weak Profitability: Average ROE of 1.83% and negative average ROCE of 1.75%
- Liquidity Concerns: Zero cash balances and ballooning trade payables
Outlook: What to Watch
Positive Catalysts
- Management communication on operational restart timeline and strategy
- Resumption of revenue generation in coming quarters
- Clarity on promoter structure and governance framework
- Working capital normalisation and trade payable reduction
- Institutional investor entry signalling confidence restoration
Red Flags to Monitor
- Continued absence of revenue in Q1 FY27 results
- Further deterioration in cash position and liquidity metrics
- Inability to service debt obligations despite low leverage
- Lack of transparency on operational challenges and turnaround plans
- Additional asset impairments or write-downs
The Verdict: Avoid Until Operational Clarity Emerges
Score: 23/100
For Fresh Investors: Strongly avoid initiating positions. The complete operational shutdown, zero promoter holding, absence of institutional support, and negative financial trend create an exceptionally high-risk profile. The valuation discount reflects fundamental concerns rather than opportunity. Wait for concrete evidence of operational revival, governance clarity, and sustained revenue generation before considering entry.
For Existing Holders: Seriously consider exiting positions at current levels to limit further downside. The operational collapse in recent quarters, combined with zero institutional confidence and persistent negative trends, suggests limited near-term recovery prospects. The 70% discount to book value may prove justified if asset realisability remains questionable. Only those with extremely high risk tolerance and long investment horizons should consider holding through a potential turnaround.
Fair Value Estimate: ₹0.20-₹0.25 (reflecting 37.50% downside risk from current levels based on stressed asset valuation and operational uncertainty)
Note- ROCE= (EBIT - Other income)/(Capital Employed - Cash - Current Investments)
⚠️ Investment Disclaimer
This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions.
